Q301--Diagnostic Medical Physicist Services RLRVAMC

Where this opportunity stands

Every notice posted under solicitation 36C25026Q0156 in this department, oldest first.

Next steps for this stage

Standard steps for the notice type; not advice about this buyer.

• Note the winner and the end of the period of performance for the recompete.
• Follow the agency to see the next notice for this work.

Who won similar work

10 award notices on SAM.gov in the last 24 months. Matched by: Same office (250-NETWORK CONTRACT OFFICE 10 (36C250)), same product/service code (PSC) Q301.

Single-winner award sizes (10): middle half $171K to $2.6M, median $331K; range $69K to $4.6M.

Value counts single-winner awards. "Shared" awards are multiple-award contracts that list every winner with the same total ceiling; that ceiling is not one company's win, so it is not added in. Revenue next to a ticker is the company's last annual revenue from its 10-K.

• Aug 31, 2026LABORATORY CORPORATION$4.6MQ301--Reference Lab Services - BCVAMC &WCBOCNo listed company matched (Materiality N/A)
• Aug 13, 2026LABORATORY CORPORATION$2.3MQ301--Reference Lab Services - SaginawNo listed company matched (Materiality N/A)
• Jul 17, 2026LABORATORY CORPORATION$2.7MQ301--Reference Lab Services - DetroitNo listed company matched (Materiality N/A)
• Jul 15, 2026OCTAVE BIOSCIENCE, INC$69KQ301--Multiple Sclerosis Disease Activity Testing John D. Dingell VA Medical CenterNo listed company matched (Materiality N/A)
• Apr 20, 2026MAYO COLLABORATIVE SERVICES, INC.$275KEsoteric Lab TestingNo listed company matched (Materiality N/A)
• Dec 30, 2025ADAPTIVE BIOTECHNOLOGIES CORPORATION$244KQ301 - ClonoSEQ Measurable Residual Disease (MRD) Testing ServicesMateriality: 0.08% of $ADPT revenue (Low)Calculated as Award Amount divided by the company's trailing twelve-month revenue (SEC 10-Q). Here: $244K award ÷ $308.1M revenue, 12 months to Jun 30, 2026 (SEC 10-Q). SEC
• Dec 23, 2025CYTOPATH BIOPSY LAB INC$146KQ301 - Thyro Seq v3 Genomic Classifier (GC) TestingNo listed company matched (Materiality N/A)
• Nov 19, 2025VERACYTE LABS SD CORPORATION$130KQ301--Decipher Prostate Testing Base- Ann Arbor, Battle Creek and SaginawMateriality: 0.02% of $VCYT revenue (Low)Calculated as Award Amount divided by the company's trailing twelve-month revenue (SEC 10-Q). Here: $130K award ÷ $561.9M revenue, 12 months to Jun 30, 2026 (SEC 10-Q). SEC
• Oct 6, 2025CYTOPATH BIOPSY LAB INC$387KQ301--ThyroSeq v3 Genomic Classifier Richard L. Roudebush VA Medical Center Indianapolis, IN 46202No listed company matched (Materiality N/A)
• Jun 30, 2025LABORATORY CORPORATION$4.0MQ301--Indy Reference Laboratory TestingNo listed company matched (Materiality N/A)

Materiality: one award's value as a share of the winner's revenue over the latest 12 months in its SEC filings (or its last fiscal year, as noted when you point at it). Low under 1%, Medium 1 to 5%, High 5% or more. Many awards are paid over several years, so this overstates a single year's share.

Competitive landscape

For the 6 most frequent past winners above. Lobbying is matched by the company's exact name or exact ticker; agencies are as named on the filings.

Policy around it

Bills the past winners named while lobbying this agency's issues, rules from the department, and executive orders that name the agency, last 12 months.

Market

For past winners matched exactly to a listed company. Insider trades are open-market buys and sells (Form 4) in the last 90 days, shown as facts; our own study found insiders do not reliably buy ahead of awards. A sale marked 10b5-1 was made under a trading plan set up in advance.